Eudald Balagué Cabasés

Title: Eudald Balagué Cabasés: Innovator in Gene Therapy

Introduction

Eudald Balagué Cabasés is a notable inventor based in Badalona, Spain. He has made significant contributions to the field of gene therapy, particularly in the treatment of genetic disorders. With a total of 2 patents, his work focuses on innovative solutions for complex medical challenges.

Latest Patents

One of Eudald's latest patents involves vectors for the treatment of Friedreich's ataxia. This invention provides gene therapies aimed at addressing this debilitating condition. Specifically, it includes a nucleic acid, cloning vector, and transfer vector for the production of an adeno-associated virus (AAV) vector. The nucleic acid comprises a sequence encoding frataxin, a phospho-glycerate-kinase (PGK) promoter, and a woodchuck hepatitis virus posttranscriptional regulatory element (WPRE). Additionally, the invention offers a pharmaceutical composition that includes the AAV vector or nucleic acid, which can be utilized as a medicament for treating Friedreich's ataxia.

Career Highlights

Eudald has worked with prominent organizations such as Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol and Gentec, S.A. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Throughout his career, Eudald has collaborated with esteemed colleagues, including Antoni Matilla Dueñas and Ivelisse Sánchez Díaz. These partnerships have fostered a collaborative environment that enhances innovation and research in gene therapy.

Conclusion

Eudald Balagué Cabasés stands out as a pioneering inventor in the field of gene therapy, with a focus on developing treatments for genetic disorders like Friedreich's ataxia. His contributions and collaborations continue to impact the medical field positively.